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Abstract
Measles virus (MV) is among the most infectious viruses that affect humans and is transmitted via the respiratory route. In
macaques, MV primarily infects lymphocytes and dendritic cells (DCs). Little is known about the initial target cell for MV
infection. Since DCs bridge the peripheral mucosal tissues with lymphoid tissues, we hypothesize that DCs are the initial
target cells that capture MV in the respiratory tract and transport the virus to the lymphoid tissues where MV is transmitted
to lymphocytes. Recently, we have demonstrated that the C-type lectin DC-SIGN interacts with MV and enhances infection
of DCs in cis. Using immunofluorescence microscopy, we demonstrate that DC-SIGN+ DCs are abundantly present just below
the epithelia of the respiratory tract. DC-SIGN+ DCs efficiently present MV-derived antigens to CD4+ T-lymphocytes after
antigen uptake via either CD150 or DC-SIGN in vitro. However, DC-SIGN+ DCs also mediate transmission of MV to CD4+ and
CD8+ T-lymphocytes. We distinguished two different transmission routes that were either dependent or independent on
direct DC infection. DC-SIGN and CD150 are both involved in direct DC infection and subsequent transmission of de novo
synthesized virus. However, DC-SIGN, but not CD150, mediates trans-infection of MV to T-lymphocytes independent of DC
infection. Together these data suggest a prominent role for DCs during the initiation, dissemination, and clearance of MV
infection.
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Introduction
Measles is a systemic disease, caused by measles virus (MV)
infection of respiratory and lymphoid tissues. MV is a member of
the Paramyxoviridae family, genus Morbillivirus. The virus is highly
contagious and is spread via the respiratory route [1]. Although
the course and symptoms of measles are well characterized, little is
known about the cellular events underlying the disease. The target
cells for MV at the site of transmission and during the systemic
phase of the disease are still under debate [1–4]. Moreover, the
interaction of MV with the immune system, paradoxically
resulting in induction of strong MV-specific immunity, but also
immunosuppression, has not been fully clarified.
It was previously thought that MV initially infects epithelial cells
of the respiratory tract, and is disseminated during viraemia by
infected monocytes [3,5]. However, these cells only express CD46,
the receptor for attenuated MV strains, but do not express CD150
(SLAM), the primary receptor for wild-type MV [6,7]. CD150 is
mainly expressed on subsets of lymphocytes, thymocytes, macro-
phages and mature dendritic cells (DCs) [7]. Moreover, we have
recently shown that lymphocytes, but not monocytes, are the
predominant cells infected in vivo during measles in macaques [2].
Moreover, lymphocytes are not in large numbers present at
respiratory epithelial surfaces compared to lymphoid tissues and
therefore we hypothesize that other cells are the target for MV at
sites of entry.
DCs are professional antigen presenting cells (APCs) that have a
sentinel function in the immune system; DCs capture antigens in
the periphery and, upon activation, migrate to the lymphoid
tissues to present the antigens to T-lymphocytes, resulting in a
pathogen-specific immune response [8]. We hypothesize that DCs
mediate transmission of MV: DCs capture MV in the respiratory
tract, but instead of degradation the virus is protected and
transported into the lymphocyte-rich area in the lymphoid tissues,
where it is efficiently transmitted to CD150+ lymphocytes. A
similar role for DCs has been described for HIV-1, where DCs
capture HIV-1 via the C-type lectin dendritic cell-specific ICAM-3
grabbing non-integrin (DC-SIGN) and mediate transmission of
HIV-1 to T-lymphocytes by de novo production of virus or
transferring the virus particles directly to the T-lymphocytes (trans-
infection) [9,10]. We have previously shown that DC-SIGN also
mediates binding of MV to DCs, which enhances DC infection
through CD150 in cis [11]. Moreover, in infected macaques MV-
infected DCs have been observed in conjunction with infected T-
lymphocytes, suggesting transmission of virus between both cell
types [2].
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Here we set out to investigate the role of DC-SIGN and CD150
in both antigen presentation and MV transmission by DCs. MV
capture by DCs leads not only to antigen presentation but also to
efficient transmission to T-lymphocytes. Both the tissue distribu-
tion and functional studies demonstrate that CD150 and DC-
SIGN have distinct functions in MV transmission by DCs. The
identification of their function in antigen presentation and MV
transmission will lead to a better understanding of MV
pathogenesis.
Results
DC-SIGN+ dendritic cells are present in the respiratory
tract and closely interact with CD150+ cells in lymphoid
tissues
MV enters the body in the respiratory tract; however the initial
target cells at the site of entry remain unknown. DC-SIGN and
CD150 are the major receptors for wild-type MV strains, of which
only CD150 can function as entry receptor. DC-SIGN is
abundantly expressed by DCs in peripheral tissues, such as the
dermis, foreskin, gut and cervix and on DCs and specialized
macrophages in the lymphoid tissues [9,12–14]. However, little is
known about the expression of DC-SIGN and CD150 in the
respiratory tract. Therefore we investigated the presence of DC-
SIGN+ and CD150+ cells in the different respiratory tissues by
immunofluorescence microscopy.
DC-SIGN was abundantly present in buccal, pharyngeal,
tonsillar, tracheal and bronchial sub-epithelial tissues (Figure 1A
and S1, Table 1). Similar to previous reports [15], scattered DC-
SIGN+ DCs were also observed in the lungs, mainly in the
interstitium of the alveoli (Table 1).
Monocyte-derived DCs (moDCs) in culture express CD150, and
expression levels are increased upon maturation [16,17]. In situ,
CD150 expression was detected on cells in the sub-epithelial
tissues of the upper respiratory tract, but we observed very little
expression in the lower respiratory tract (Figure 1A and S1,
Table 1). Although some CD150+ cells were present in the
epithelia of the tonsillar crypts and the pharynx, the expression of
CD150 in these tissues was low compared to that in lymphoid
tissues (Figure 1A and S1, Table 1). These cells might represent
macrophages or lymphocytes that can be targets for MV infection
and their infection might explain why infection is observed in
epithelial tissues in vivo [2]. We also observed some autofluores-
cence in the epithelia of the tracheal, bronchial and tonsillar
epithelium, probably caused by mucus (Figure 1A and S1). In the
upper respiratory tract, we rarely detected co-localization of
CD150 and DC-SIGN, suggesting that DC-SIGN+ DCs, abun-
dantly present just below the epithelia in the respiratory tract,
express no or low levels of CD150 (Figure 1A and S1, Table 1).
During viraemia, MV-infected cells enter the lymphoid tissues.
Here, DC-SIGN+ DCs might facilitate infection of lymphocytes,
similar to HIV-1 [9]. We therefore investigated the expression of
DC-SIGN and CD150 in lymph node and tonsil. As previously
described [13,15], DC-SIGN+ cells were mainly located around
the medullary sinuses and in the paracortex (T-cell areas) of the
lymph node as well as in the inter-follicular tissue (T-cell area) of
the tonsil (Figure 1B, Table 1). However, DC-SIGN+ cells were
also found in the B cell follicles of the tonsil. Notably, DC-SIGN+
cells were located in close contact with the CD150+ cells
(Figure 1B). Strikingly, strong co-localisation of DC-SIGN and
CD150 was observed in the medullary sinuses (Figure 1B, Table 1).
Together these data suggest that DC-SIGN+ cells are not only
important in the initial phase of MV infection, but might also be
involved in MV infection in the lymphoid tissues during the
systemic phase of the infection.
Dendritic cells mediate antigen presentation of measles
virus to CD4+ T-lymphocytes
DC-SIGN is an attachment receptor for MV and mediates
infection of DCs through CD150 in cis [11]. We investigated
whether MV capture by DC-SIGN+ DCs also leads to antigen
processing and presentation to MV-specific CD4+ T-lymphocytes.
We performed an antigen presentation assay using MV-specific
CD4+ T cell clones. [18,19]. As APCs we used moDCs, expressing
high levels of DC-SIGN [20] or an autologous Epstein-Barr virus-
transformed B-lymphoblastic cell line (BLCL). The APCs were
incubated with different dilutions of MV that was UV-inactivated
to exclude DC and T-lymphocyte infection. Subsequently the
APCs were co-cultured with the MV-specific CD4+ T-cell clones.
At the highest concentrations, UV-MV induced DC maturation,
since CD86 was upregulated, whereas DC-SIGN was down-
regulated (Figure 2A). Notably, in contrast to LPS stimulation,
HLA-DR was not upregulated by MV. T-cell activation was
measured by the detection of IFN-c production by ELISPOT and
ELISA. We used two different MV-specific T cell clones (GRIM99
and GRIM61) that matched and one that mismatched (GRIM 76)
the HLA type of the donor DCs. DCs incubated with UV-
inactivated MV specifically activated the HLA-matched MV-
specific T cell clones, whereas the mismatched MV-specific T cell
clone was not activated (Figure 2B and C). Moreover, an irrelevant
T cell clone (LB5) was not activated by the DCs (Figure 2B). Thus,
MV capture by DCs leads to specific antigen processing and
presentation of MV peptides in the context of MHC-class II
molecules. MV-derived antigen presentation by DCs was more
efficient at low antigen concentrations than presentation by
autologous BLCL (Figure 2B); while the peptide control response
was not significantly different (239+/216 versus 264+/218).
To investigate whether DC-SIGN and CD150 are involved in
antigen presentation, moDCs were pre-treated with specific
blocking antibodies to CD150, DC-SIGN and with the C-type
lectin inhibitor mannan. Both mannan and anti-DC-SIGN
inhibited activation of the MV-specific T-cell clone, demonstrating
that DC-SIGN supports MV antigen uptake and processing for
antigen presentation (Figure 2B and C). Notably, antibodies
against CD150 also inhibited T-cell clone activation, although to a
lesser extent than antibodies against DC-SIGN. The role of DC-
Author Summary
Despite the availability of an effective vaccine, measles
virus (MV) is still a major cause of childhood morbidity and
mortality in developing countries. Almost all non-vacci-
nated children catch the highly contagious virus during an
MV outbreak. This suggests an efficient route for primary
infection. However, the main target cells for MV replica-
tion, CD150+ lymphocytes, are barely present in the
respiratory tract where MV enters the body. Here we
demonstrate an alternative route of MV transmission:
dendritic cells that are abundantly present in the sub-
epithelial tissues of the respiratory tract may capture MV
through binding to either CD150 or DC-SIGN. Although
some virus particles are processed for antigen presenta-
tion, others escape from degradation. After virus capture,
DCs migrate to the lymphoid tissues where they encounter
CD150+ lymphocytes and transmit the virus, after which
viral replication is started. Our data provide new insights
into the transmission of measles virus, and suggest a dual
role for DCs in the pathogenesis of measles.
DCs Mediate Transmission of MV to T-Lymphocytes
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SIGN and CD150 was not dependent on post-entry effects, since
addition of the antibodies just before the T-lymphocytes
were added did not affect MV antigen presentation to the CD4+
T-cell clone (data not shown). Thus, viral uptake by DC-
SIGN and to a lesser extent CD150 leads to virus degradation
and antigen presentation of MV-derived antigens to CD4+
T-lymphocytes.
Measles virus replicates in clusters of dendritic cells and
T-lymphocytes that are interconnected by infected
dendrites
DCs capture HIV-1 via DC-SIGN [9], and facilitate the infection
of T-lymphocytes by transferring the virus through the infectious
synapse [21]. Since DC-SIGN+ DCs and CD150+ lymphocytes
Figure 1. DC-SIGN+-dendritic cells are present in the sub-epithelial tissues of the respiratory tract. (A,B) Cryosections of different tissues
from healthy donors were stained for the expression of DC-SIGN (green) and CD150 (red) using specific antibodies, and for the nuclei using Hoechst
(blue). The sections were analyzed by fluorescence microscopy. (A,B) Representative photos with a magnification of 1006 are depicted
(e = epithelium; s = sub-epithelial tissue, i = inter-follicular, f = follicles, m=medullary sinus, p = paracortex, arrow= autofluorescence, * = co-
localization).
doi:10.1371/journal.ppat.1000049.g001
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closely interact in the lymphoid tissues and the upper respiratory
tract (Figure 1), we investigated the role of DCs in MV transmission
in DC-T-lymphocyte co-cultures. To analyse viral transmission of
DCs to T-lymphocytes we used the recombinant MV-IC323-EGFP
strain. This MV strain has similar characteristics as its parental IC-B
wild-type strain [22], but infected cells produce high amounts of
EGFP. The concentration of EGFP in the cells is directly related to
the level of virus replication. The entry receptor for this virus is
CD150, and not CD46, similar as MV wild-type strains [6]. DCs
were infected with MV-IC323-EGFP, and subsequently co-cultured
with PHA-stimulated T-lymphocytes expressing high levels of
CD150. After two days the infected cells were analyzed by
fluorescence microscopy. MV infection induced the formation of
large clusters, which contained multiple EGFP+ syncytia (Figure 3A).
Most infected cells were observed in clusters, and notably long
EGFP+ dendritic processes were observed that interconnected these
clusters (Figure 3A). To investigate which cells were present in the
clusters, either DCs or T-lymphocytes were stained with a red dye
before infection. Staining of either cell type demonstrated that both
infected DCs and T-lymphocytes were present in the EGFP+ clusters
(Figure 3B), reminiscent of the in vivo infection of DCs and T-
lymphocytes observed in lymphoid tissues of macaques [2].
To investigate whether DCs enhance the infection of lympho-
cytes, T-lymphocytes or DC-T-lymphocyte co-cultures were
infected with different concentrations of MV-IC323-EGFP and
subsequently analyzed by flow cytometry. MV could readily infect
activated T-lymphocytes, but addition of DCs enhanced infection
two-fold (Figure 3C and D). To investigate the role of DC-SIGN
in MV transmission in a DC-T-lymphocyte co-culture, DCs were
pre-incubated with mannan and infection was measured. Mannan
partially prevented the increased infection of the lymphocytes in
the DC-T lymphocyte co-cultures, demonstrating that DC-SIGN
is involved in the enhanced infection in the DC-T lymphocyte co-
culture, probably by increasing viral transmission to T-lympho-
cytes (Figure 3D).
Dendritic cells transmit measles virus to T-lymphocytes
independently of de novo virus production
To investigate whether DCs transmit MV to their target cells,
DCs were incubated with MV-IC323-EGFP for two hours,
washed extensively to remove unbound virus and subsequently
co-cultured with activated T-lymphocytes. In DC cultures without
T-lymphocytes, low percentages of MV-infected DCs were
detected, whereas in the DC-T lymphocyte co-cultures large
clusters of MV-infected cells and syncytia were observed (Figure 4A
upper panels). These data strongly suggest that DCs capture MV
and transmit the virus to T-lymphocytes independently of de novo
synthesis of virus by infected DCs, since only a few infected DCs
were observed (Figure 4A). This process is referred to as trans-
infection. However, HIV-1 studies have shown that DCs can also
mediate transmission of de novo synthesized HIV-1 [10]. DCs in the
respiratory tract in situ express high levels of DC-SIGN and no or
low amounts of CD150 (Figure 1), suggesting that DCs are not
productively infected by MV. Therefore, we investigated whether
DCs mediate trans-infection. As demonstrated, DCs transmit MV
efficiently to T-lymphocytes in a co-culture (Figure 4A) but de novo
synthesis in DCs cannot be excluded, since both DCs and T-
lymphocytes are infected in the DC-T lymphocyte co-culture
(Figure 4B). To exclude de novo synthesis of virus in DCs, we used
the fusion inhibitor peptide (FIP, 200mM) [23], which was added
to the co-cultures 2 hours after addition of the T-lymphocytes to
MV-infected DCs. We observed large clusters of EGFP+ cells in
the presence of FIP (Figure 4A). FIP prevents fusion of MV with
cell membranes and of membranes of MV-infected cells with those
of neighbouring cells. Therefore FIP blocks infection and
syncytium formation [24]. Thus, T-lymphocytes expressing EGFP
must have been infected during the 2 hours co-cultivation with
MV-infected DCs before FIP was added (Figure 4B). This is a time
frame that excludes de novo synthesis of MV by the DCs. In
contrast to the condition without FIP, no syncytium formation was
observed in DCs and T-lymphocytes cultured in the presence of
Table 1. DC-SIGN+-dendritic cells are present in the sub-epithelial tissues of the respiratory tract.
Tissues CD150# DC-SIGN Co-localization n
Upper respiratory tract Buccal cavity Epithelium 0 0 0 1
Sub-epithelium + +++ 0/+
Pharynx Epithelium + 0 0 1
Sub-epithelium + +++ 0
Tonsillar crypt Epithelium 0/+ 0 0 2
Sub-epithelium + +++ 0
Lower respiratory tract Trachea Epithelium 0 0 0 2
Sub-epithelium 0/+ ++ 0
Bronchus Epithelium 0 0 0 2
Sub-epithelium 0 ++ 0
Lung Interstitium 0/+ 0/+ 0 2
Lymphoid tissue Tonsil Folicle +++ +++ ++ 3
Inter-folicular +++ +++ ++
Lymph node B-cell area +++ + + 1
T-cell area +++ ++ ++
Medullary sinus +++ +++ +++
#The number of DC-SIGN+- or CD150+- cells was determined by counting the number of positive cells, divided by the total number of cells, based on the nuclei staining.
The double-positive cells were divided by the total number of stained cells, to determine the co-localization. 0 = 0–1%, +=1–5%, ++=5–25%, +++=25–100% of the
cells, n = number of donors analyzed per tissue.
doi:10.1371/journal.ppat.1000049.t001
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Figure 2. Dendritic cells mediate antigen presentation of measles virus to CD4+ T-lymphocytes. (A) DCs (16105 cells) were incubated
with different concentrations of UV-MV. After 24 hours, the cells were stained for CD150, HLA-DR, CD86 and DC-SIGN using specific antibodies and
analyzed by flow cytometry. (B,C) DCs or autologous B cells (BLCL) (56104 cells) were pre-incubated with mannan and incubated with UV-MV or a
positive control peptide overnight. The MV-specific CD4+ T-cell clones, GRIM99, GRIM61 and GRIM76 and the non-specific T-cell clone LB5 were
DCs Mediate Transmission of MV to T-Lymphocytes
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FIP, confirming that FIP indeed prevented fusion. Moreover,
incubation of DCs with different concentrations of MV demon-
strated that T-lymphocytes were the major MV-infected cell
population in the DC-T lymphocyte co-culture (Figure 4C),
demonstrating that DCs mediate trans-infection. To determine the
efficiency of the trans-infection, the absolute number of infected
cells was calculated (Figure 4D). A 6-fold higher number of T-
lymphocytes compared to DCs were infected in the co-cultures.
This demonstrates that trans-infection of T-lymphocytes by DC-
bound MV is more efficient than cis-infection of DCs. Thus, DCs
efficiently mediate transmission of MV to T-lymphocytes, and this
process primarily occurs independently of de novo synthesis of MV.
Measles virus trans-infection of T-lymphocytes by
dendritic cells is dependent on DC-SIGN, but not CD150
DC-SIGN and CD150 are both important for binding of MV to
DCs and subsequent infection. Indeed, MV-infection of DCs is
added and T cell activation was determined by ELISPOT. GRIM99, GRIM61 and LB5 were dependent on HLA-DQw1 as expressed by the DCs, whereas
GRIM76 was HLA-mismatched to the DCs used. Images of the ELISPOT (left) and the mean of the spot counts per well are depicted (right). Error bars
represent the standard deviation of duplicates. (D) DCs (16104 cells) were pre-incubated with mannan, anti-DC-SIGN or anti-CD150 and subsequently
incubated with different concentrations of UV-MV. After 6 hours the MV specific CD4+ T-cell clone (56104 cells) was added to the wells. After
24 hours the supernatant was harvested and the amount of IFN-c analyzed by ELISA. Standard deviations represent the standard deviation of
duplicates. A representative experiment out of two is shown.
doi:10.1371/journal.ppat.1000049.g002
Figure 3. Dendritic cells facilitate measles virus infection of T-lymphocytes in clusters that are interconnected. (A–D) T-lymphocytes
(26105 cells), alone or in the presence of DCs (56104 cells), were pre-incubated with mannan and infected with MV-IC323-EGFP (TCID50 5610
4 unless
depicted otherwise) and cultured for 72 hours. (A,B) The infection was analyzed by fluorescence microscopy. The magnification is depicted. (B) DCs or
T-lymphocytes were labeled red using the membrane dye PKH26 prior to the experiment and infection by MV-IC323-EGFP is shown by EGFP
expression (green). (C,D) The infection of DCs and T-lymphocytes was analyzed by measuring EGFP expression by flow cytometry. Standard
deviations represent the standard deviation of triplicates. A representative experiment out of two is shown.
doi:10.1371/journal.ppat.1000049.g003
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Figure 4. Dendritic cells mediate viral transmission of measles virus independently of de novo virus production. (A–D) DCs (56104
cells) were incubated with MV-IC323-EGFP (56104TCID50, unless depicted otherwise) and after 2 hours the cells were extensively washed. T-
lymphocytes (26105 cells) were added and if indicated the fusion inhibitory peptide (FIP) was added after 2 hours. After 72 hours the infection was
analyzed by (A) fluorescence microscopy and (B–D) flow cytometry. (A) The cultures are depicted as an overlay of EGFP and brightfield. (B,C) The cells
DCs Mediate Transmission of MV to T-Lymphocytes
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inhibited by antibodies against CD150 and DC-SIGN, as well as
by mannan (Figure 5A) [11]. MV transmission by de novo synthesis
of MV particles depends on infection of DCs and therefore these
data suggest that transmission through de novo synthesis of virus is
dependent on both CD150 and DC-SIGN.
To investigate whether DC-SIGN is involved in MV trans-
infection of T-lymphocytes, DCs were pre-treated with mannan or
antibodies against DC-SIGN and transmission was measured in the
presence of FIP. In all donors, both mannan and antibodies against
DC-SIGN inhibited trans-infection (Figure 5B), although donor
variations were observed. Direct infection of T-lymphocytes after
pre-treatment with the blocking agents demonstrated that these
compounds do not interfere with the infection of the target cells
(Figure 5B). Allogeneic DCs induce T-lymphocyte activation and as
such might increase CD150 expression and subsequently MV
infection of T-lymphocytes. Therefore, we used autologous T-
lymphocytes for donors#5–7. In this setting, trans-infection was also
observed and was dependent on DC-SIGN (Figure 5B), indicating
that trans-infection is independent of T-lymphocyte activation. To
analyze whether these differences were significantly different
throughout the donors, data were normalized to the medium
condition (Figure 5C), demonstrating that DC-SIGN is important
for transmission of MV from DCs to T-lymphocytes (Figure 5C).
Since CD150 is important for MV binding to DCs and
subsequent infection, we investigated whether this receptor is also
important for trans-infection of T-lymphocytes. Strikingly, anti-
bodies against CD150 did not block the trans-infection and even
slightly increased the transfer to T-lymphocytes (Figure 5D). These
results demonstrate that DC-SIGN mediates both DC infection in
cis and trans-infection, whereas CD150 is only involved in
infection, and thus CD150 and DC-SIGN have distinct roles in
MV transmission by DCs to T-lymphocytes.
DCs transmit MV to both CD4+ and CD8+ T-lymphocytes
In peripheral blood of experimentally infected macaques, MV
infection of both CD4+ and CD8+ T-lymphocytes was observed [2].
Therefore we investigated whether DCsmediate transmission of MV
to both T-lymphocyte subsets in vitro. CD4+ and CD8+ T-
lymphocytes were purified from PHA-stimulated human peripheral
blood mononuclear cells (PBMCs), and both expressed high levels of
CD150 (Figure 6A). DCs were infected with MV-IC323-EGFP, and
after extensive washing, co-cultured with either CD4+ or CD8+ T-
lymphocytes. In both co-cultures, EGFP expression was observed in
large clusters containing EGFP+ syncytia, demonstrating that DCs
mediate transmission to both T-lymphocyte subsets (Figure 6B). To
measure whether DCs mediate trans-infection, FIP was added two
hours after addition of the T-lymphocytes to the MV-infected DCs.
Trans-infection to both subsets is efficient and mediated by DC-
SIGN, since pre-treatment of DCs with mannan inhibited infection
of T-lymphocytes in both cultures (Figure 6C). Thus, DCs transmit
MV to both CD4+ and CD8+ T-lymphocytes.
Discussion
Two hallmarks of measles are that the virus is highly contagious
and infection results in strong MV-specific cellular immune
responses. Both viral transmission and antigen presentation should
therefore occur through efficient and robust processes. Since DCs
are professional APCs and have been demonstrated to mediate
transmission of several viruses, we have investigated the role of
DCs in both processes for measles. Here we have shown that a
subset of DCs, the DC-SIGN+ DCs, mediates both transmission
and antigen presentation of MV to T-lymphocytes. The receptors
DC-SIGN and CD150 are both involved in DC infection and
antigen presentation, whereas only DC-SIGN is involved in MV
trans-infection of T-lymphocytes.
DC-SIGN+ DCs have previously been identified in several sub-
epithelial and lymphoid tissues [9,13]. Here, we have identified
DC-SIGN+ DCs in the sub-epithelial tissues of the human mouth,
pharynx, trachea and bronchi, and the presence of scattered DC-
SIGN+ cells in the lung. CD150 is expressed on in vitro cultured
macrophages and DCs and is increased upon maturation
[16,17,25]. However, CD150 was previously not detected on
immature DCs in skin and lung in situ [26] and we could not detect
CD150 on DC-SIGN+ DCs in respiratory epithelia, suggesting
that these DCs are not susceptible to MV infection and DCs
capture MV through DC-SIGN. However, expression of low levels
of CD150 that might support MV infection cannot be excluded
using immunofluorescence microscopy. DC-SIGN strongly en-
hances infection of DCs through CD150 [11], and therefore low
levels of CD150 might be enough for efficient infection of DCs.
Different mechanisms are involved in virus transmission by DC-
SIGN, since HIV-1 capture by DC-SIGN can result both in cis and
trans-infection [9,27]. However, DC-SIGN binding of HIV-1 also
leads to virus degradation and presentation in the context of MHC
[28,29]. Interestingly, we observed that both DC-SIGN and CD150
are involved in MV processing and presentation of MV-derived
peptides to the MV-specific CD4+ T-cell clone GRIM99. B cells are
able to presentMV antigens to T cells [30]. BLCL express high levels
of CD150, but no DC-SIGN and MV capture leads to virus
degradation and presentation of MV peptides to the autologous
CD4+ T-cell clone and this was previously demonstrated to be
dependent on endocytosis [30]. Notably, DCs were more efficient in
antigen processing and presentation than the autologous BLCL and
antibodies against DC-SIGN inhibited antigen presentation to a
larger extent than antibodies against CD150. Thus, although both
DC-SIGN and CD150 are involved, DC-SIGN is more important
for antigen presentation of MV by DCs.
MV is a highly contagious virus [1] suggesting that it has a very
efficient entry into the respiratory tissues. However, the number of
CD150+ target cells in the respiratory tract is low, suggesting that
these are not the first targets for MV at the site of entry. In
contrast, the tissue is lined with DC-SIGN+ DCs and these DCs
are better candidates since DC-SIGN+ DCs efficiently capture
MV and mediate transmission of MV to T-lymphocytes in vitro.
MV transmission to non-stimulated lymphocytes by DCs was
inefficient (data not shown), which is in line with a previous report
that demonstrated that transmission of MV from DCs to T cells
isolated from blood is inefficient [31]. This is probably due to low
expression of CD150 on blood-derived lymphocytes. However in
lymphoid tissues, where DCs migrate to, CD150 is highly
expressed on T and B-lymphocytes and on monocytes [7,32].
Recently it was demonstrated that DCs specifically transmit
HIV-1 to HIV-1-specific T-lymphocytes [29] suggesting that
immunological synapse formation enhances viral transmission, due
to prolonged interactions during antigen presentation and T cell
were harvested, washed and stained for CD3 and DC-SIGN. EGFP expression was measured by flow cytometry. (B) The percentage gated is depicted in
the regions or quadrants. (C) Transmission of different concentrations of MV IC323-EGFP is analyzed. (D) The absolute numbers of EGFP+ DCs and T-
lymphocytes in the analyzed samples were calculated and depicted. Error bars represent the standard deviation of triplicates. A representative donor
out of seven is shown.
doi:10.1371/journal.ppat.1000049.g004
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Figure 5. Trans-infection of measles virus by dendritic cells is dependent on DC-SIGN, but not on CD150. (A–D) DCs (56104 cells) or (B) T-
lymphocytes from different donors were pre-incubated with mannan, anti-DC-SIGN or anti-CD150 (for donor #1 and #2), before incubation with MV-
IC323-EGFP (56104 TCID50). (A) The cells were cultured in the presence of FIP for 3 days and analyzed by flow cytometry. (B–D) After 2 hours the cells were
washed and T-lymphocytes (26105 cells) were added. For donor#5–7 autologous T-lymphocytes were used as target cells. The fusion inhibitory peptide
(FIP) was added after 2 hours. After 72 hours the cultures were analyzed by flow cytometry. (B) Transmission by different donors of DCs is depicted. As a
control for the specificity of mannan and anti-DC-SIGN T-lymphocytes were pre-treated and directly infected. Error bars represent the standard deviation
of triplicates. (C) The results of the different donors in (B) (#1–7) were normalized to the medium control to determine the statistical differences by
ANOVA. Error bars represent the standard deviation of the mean of the different donors, *** =p,0,01 versus the medium control.
doi:10.1371/journal.ppat.1000049.g005
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activation. However, we did not observe differences between
transmission to autologous- and allogeneic T-lymphocytes,
suggesting that prolonged immunological synapse interactions
occurring during allogeneic but not autologous T-DC interactions
are not necessary for MV transmission. This might be due to
differences in infectivity between both viruses.
MV transmission can occur independently of de novo synthesis of
virus in DCs (referred to as trans-infection). Using specific blocking
antibodies, we have demonstrated that trans-infection is dependent
on DC-SIGN but not on CD150. This is physiologically relevant,
since DC-SIGN+ DCs in the respiratory tract express no or low
levels of CD150, and are therefore not susceptible to MV
infection. Both DC-SIGN and CD150 are important for binding
of MV to DCs [11]. However, our data show that binding of MV
to DC-SIGN and CD150 results in different internalization
pathways. Although both DC-SIGN and CD150 lead to virus
degradation for antigen presentation, CD150 binding also results
in viral entry, whereas only the interaction of DC-SIGN with MV
Figure 6. Dendritic cells mediate transmission of measles virus to both CD4+ and CD8+ T-lymphocytes. (A) PBMCs were activated for
three days, and the cells were enriched for CD4+ T-lymphocytes or CD8+ T-lymphocytes. T-lymphocytes and DCs are stained for the expression of
CD150 and analyzed by flow cytometry. Open histograms represent isotype-control and filled histogram the specific antibody staining. The mean of
the specific staining is depicted. (B,C) DCs (56104 cells) were pre-incubated with mannan before incubation with MV-IC323-EGFP (56104 TCID50).
After 2 hours the cells were washed and cultured in the presence of the CD4+ or CD8+ T-lymphocytes for three days. (B) The cultures were analyzed
by fluorescence microscopy and pictures were made at a magnification of 2006 (C) The fusion inhibitory peptide (FIP) was added after 2 hours. The
cells were harvested and EGFP expression was measured by flow cytometry. Standard deviations represent the standard deviation of triplicates. A
representative experiment out of two is shown.
doi:10.1371/journal.ppat.1000049.g006
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leads to viral protection for trans-infection. Indeed, inhibition of
CD150 resulted in enhanced trans-infection due to less degradation
or fusion and therefore increasing the amount of virus for the DC-
SIGN-mediated transmission. Several donors were tested for the
involvement of DC-SIGN in trans-infection of MV. The contribution
of DC-SIGN varied between the donors, suggesting that another
attachment receptor might play a role, such as syndecan-3 for HIV-1
[33]. In macaques, both CD4+ and CD8+ T-lymphocytes are
infected during the viraemic phase of measles disease [2]. It is
unclear whether viral transmission can also occur to CD8+ T
lymphocytes. Interestingly, we observed MV transmission by DCs to
both CD4+ and CD8+ T-lymphocytes, indicating the formation of
an infectious synapse between DCs and CD8+ T-lymphocytes,
similar to DCs and CD4+ T-lymphocytes [21].
During MV infection in macaques, lymphoid tissues are major
sites of MV replication [2]. In human lymphoid tissues, CD150+-
and DC-SIGN+ cells are in close contact, which can contribute to
massive replication of MV. This is supported by our in vitro
observations that DC-SIGN+ DCs enhance infection of T-
lymphocytes in co-cultures and MV infection is predominantly
observed in the clusters of DCs and T-lymphocytes. Notably, long
EGFP+ dendrites were frequently observed between clusters,
suggesting that viruses spread between clusters through these
dendrites. Although these dendrites might be a MV-specific effect,
which facilitates virus spread, these dendritic processes might also
have a physiological function in the immune system, such as the
interchange of antigenic information. The fact that MV infection
in DC-T lymphocyte co-cultures was observed in clusters was
highly reminiscent to the infectious foci that we have previously
observed in tissues of infected macaques [2]. This pattern and
enhanced infection in DC-T lymphocyte co-cultures suggest that
the virus is much more efficiently transmitted by direct cell-cell
contact than as cell-free virus.
In contrast to the APCs in the peripheral tissues, the borders of
the medullary sinuses of the lymph node contain a population of
cells that express high amounts of both DC-SIGN and CD150.
These DC-SIGN+ cells have been previously shown to express
CD68 and lack the expression of DEC205, suggesting that these
cells are medullary macrophages [13,34]. These cells are in
contact with the lymph and therefore encounter tissue-derived
antigens. Based on the high expression of both CD150 and DC-
SIGN, and the fact that DC-SIGN can enhance infection in cis
[11], it is likely that these cells become infected during measles and
might contribute to further virus transmission.
In conclusion, these data provide us with an alternative view on
how MV might disseminate from the site of infection to their main
target cells, the lymphocytes: DC-SIGN+ DCs, which are
abundantly present in the sub-epithelial tissues of the respiratory
tract, capture MV and process the virus for antigen presentation,
but a part of the virus escapes from degradation. In previous
studies dendrites of sub-epithelial DCs have been shown to pass
the tight junctions of the epithelium of the gut and respiratory tract
and sample the mucosal surfaces [35], which could result in
efficient capture of the virus. Moreover, MV induces activation of
the DC via TLRs [36], which will induce migration of DCs from
the peripheral tissues to the lymphoid tissues. Although DCs might
encounter CD150+ cells in the underlying mucosal tissues, the
abundant expression of CD150 in lymphoid tissues strongly
suggests lymphoid tissues as the major site of MV transmission and
replication. A similar mechanism might play a role in spreading
the virus throughout the body, even to privileged tissues such as
the brain, and could therefore be involved in complications such as
subacute sclerosing panencephalitis (SSPE). Moreover, during
viraemia, DCs might increase infection and tissue destruction. In
the future, in vivo studies will be required to prove the importance
of MV transmission by DCs.
Materials and Methods
Antibodies
The following antibodies were used: CD150-specific mouse
antibody 5C6 [37], DC-SIGN-specific mouse antibodies AZN-D1
and AZN-D2 [9], DCN46 and DCN46 conjugated with PE (BD
Pharmingen, San Diego, CA, USA), CD3-specific mouse antibody
SK-7 conjugated with PerCP (BD Pharmingen, San Diego, CA,
USA), goat anti-mouse IgG antibody conjugated with PO (Jackson
Immunoresearch, West Grove, PA, USA), HLA-DR- (Immu357)
and CD86- (HA5.2B7) specific mouse antibodies conjugated with
PE (Immunotech, Marseille, France), goat anti-mouse antibody
conjugated with FITC (Zymed Laboratories Inc., South San
Fransisco, CA. USA), Alexa488- or Alexa594-labeled anti-mouse
antibodies (Molecular probes, Eugene, OR, USA).
Cells
Vero-CD150 cells [38] were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM; Gibco Invitrogen, Carlsbad, CA, USA)
supplemented with 4500 mg/L glucose; 110 mg/l sodium pyru-
vate; 4 mM L-glutamine; 10% heat-inactivated fetal calf serum
(FCS); 20 U/ml penicillin and 20 mg/ml streptomycin, at 37uC
with 5% CO2. The CD4
+ HLA-DQw1-restricted T-cell clone
GRIM99 [18,19] recognizes an epitope in the MV fusion protein
(EVNGVTIQV). GRIM61 and GRIM99 are also MV-specific
CD4+ T cell clones, for which the epitopes have not been mapped
(Van Binnendijk JI 1989). LB5 is a CD4+ T cell clone of unknown
specificity (unpublished). All clones were cultured in RPMI-1640
(RPMI 1640, Gibco Invitrogen, Carlsbad, CA, USA) supplement-
ed with 4 mM L-glutamine; 10% heat-inactivated human AB
serum (Sigma-Aldrich, St. Louis, MO, USA); 20 U/ml penicillin,
20 mg/ml streptomycin and 1025 M 2-mercapto-ethanol in 96-
well round bottom plates. Epstein-Barr virus-transformed B-
lymphoblastic cell line (BLCL-GR) [18,19] was used as autologous
APC, and was cultured in RPMI 1640 supplemented with L-
glutamine, penicillin, streptomycin and 10% FCS. Immature
moDCs were cultured as described before [39]. In short, human
blood monocytes were isolated from buffy coats by Ficoll density
centrifugation, followed by selection of CD14+ cells using magnetic
beads (MACS, Milteny Biotec GmbH, Bergisch Gladbach,
Germany). Purified monocytes were cultured in RPMI-1640
medium supplemented with 4 mM L-glutamine; 10% FCS; 20 U/
ml penicillin and 20 mg/ml streptomycin and differentiated into
immature moDCs in the presence of IL-4 and GM-CSF (500 and
800 U/ml, respectively; Schering-Plough, Brussels, Belgium).
PBMCs were isolated from buffy coats by Ficoll density
centrifugation, activated with phytohemagglutinin (3 mg/ml; Sig-
ma-Aldrich, St. Louis, MO, USA), and cultured in complete RPMI-
1640medium. At day 3 the cells were washed and cultured with IL-2
(100 units/ml). As determined by flow cytometry .80% of the
activated PBMC were CD3+ and therefore these cells are referred to
as T-lymphocytes throughout the text. The CD4+ and CD8+ T-
lymphocytes were enriched at day 3 after PHA stimulation by
negative selection using MACS beads. To label DCs and T-
lymphocytes, the cells were stained with the PKH26 red fluorescent
cell linker kit (Sigma-Aldrich, St. Louis, MO, USA) for general cell
membrane labelling, according to the manufacturers protocol.
Viruses
The recombinant MV strain IC323-EGFP [40] was propagated
on Vero-CD150 cells. For virus production, Vero-CD150 cells
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were infected with a multiplicity of infection (MOI) of 0.01 in
DMEM supplemented with 2% of FCS. After 90 minutes cells
were washed to remove unbound virus and were subsequently
grown in DMEM supplemented with 10% FCS. Cells and
supernatant were harvested when 80% cytopathic effect was
observed. To release cell-bound virus, the cells were sonicated (3
times, 10 seconds, Sonicor Instrument Corporation, Copiaque,
N.Y., USA). The cells were centrifuged (10 minutes, 1000 g) and
the supernatant was snap-frozen in liquid nitrogen before titration
on Vero-CD150 cells. The titer of the virus-stock used was 16106
TCID50/ml. Purified MV Edmonston with a concentration of
approximately 1 mg/ml, was inactivated by UV-irradiation
(30 minutes, 15W 312 nm) and is referred to as UV-MV
throughout the text.
Immunofluorescence Microscopy
Tissues of healthy human donors were obtained through the
pathology department of the VU University Medical Center,
according to the institutional ethical guidelines. Cryosections
(7 mm) were fixed with 100% acetone and stained with primary
antibody combinations against DC-SIGN (DCN46, IgG2b, 10 mg/
ml) and anti-CD150 (5C6, IgG1, 10 mg/ml) or a buffer control for
18 hours at 4uC. Sections were counterstained with isotype-specific
Alexa488- or Alexa594-labeled anti-mouse antibodies. Nuclei were
stained with Hoechst (Molecular Probes, Eugene, OR, USA). After
mounting, sections were examined with a Nikon Eclipse E800
fluorescence microscope and recordings were made with a digital
NIKON DXM1200 camera. Two persons used the photographs to
quantify the staining in the different tissues independently. To
determine the density of DC-SIGN+- or CD150+ cells, the number
of positive cells was divided by the total number of cells, based on the
nuclei staining. To determine the co-localization, the double-stained
cells were divided by the total number of stained cells. Based on the
control sections, autofluorescence was often observed in the lower
respiratory tract and is indicated in the pictures.
Antigen Presentation Assays
Monocytes were isolated from an HLA-DQw1-matched donor
using CD14 MACS beads and differentiated into immature DCs as
described above. Subsequently, these DCs or autologous BLCL-GR
(56103 cells) were used as APCs in an interferon-c (IFN-c)
ELISPOT assay as previously described [41]. Briefly, APCs were
plated into 96-well v-bottom plates in complete RPMI-1640
containing IL-4 and GM-CSF and pre-incubated with mannan
(0,25 mg/ml) for 30 minutes at 37uC. Next, the cells were incubated
with different dilutions of UV-MV at 37uC or a positive control
peptide (EVNGVTIQV; 1 mM). After overnight incubation the
CD4+ T-cell clones were added to the APCs (56103 cells per well),
the plates were briefly centrifuged (1 minute, 300 g) and subse-
quently incubated at 37uC for 1.5 hour. Subsequently the cells were
transferred to nylon bottom plates (Nalge Nunc International,
Rochester, NY) coated with a monoclonal antibody specific for
human IFN-c (1-D1K; Mabtech, Stockholm, Sweden), and
incubated at 37uC for five hours. Finally, plates were washed with
phosphate-buffered saline (PBS) containing 0.05% Tween 20
(Merck, Darmstadt, Germany). Spots were visualized by incubation
with a secondary biotinylatedmAb against IFN-c (7-B6-1; Mabtech),
followed by staining with streptavidin–alkaline phosphatase (Mab-
tech), and nitroblue tetrazolium–5-bromo-4-chloro-3-indolyl-phos-
phate (Kirkegaard & Perry Laboratories, Gaithersburg, MA, USA).
Finally, the color reaction was stopped by washing the plates with
water and spots were counted with an automated ELISPOT reader
(automated ELISAspot assay video analysis systems; distributed by
Sanquin Reagents, Amsterdam, The Netherlands).
In parallel, the same APCs were also used to stimulate the same
T-cell clone for IFN-c production in supernatant. Briefly, APCs
(16104 cells) were used to stimulate the T-cell clone (36104 cells)
in round-bottom plates, and were incubated at 37uC for 24 hours
before supernatants were harvested. To determine the contribu-
tion of DC-SIGN and CD150, the APCs were pre-incubated with
mannan (0,25 mg/ml), anti-DC-SIGN (AZN-D2; 20 mg /ml) or
anti-CD150 (5C6; 20 mg/ml) for 30 minutes at 37uC. The IFN-c
concentrations in the supernatants were determined by ELISA
(Biosource International, CA, USA).
MV Infection, Transmission and Co-culture Assays
For infection and transmission assays DCs (56104 cells) were
seeded in a V-bottom plate and pre-incubated with mannan
(0,25 mg/ml), anti-DC-SIGN (AZN-D2; 20 mg/ml) or anti-
CD150 (5C6; 20 mg/ml) for 30 min. at 37uC, before incubation
with MV-IC323-EGFP at 37uC for 2 hours (56104 TCID50,
unless stated otherwise). After 2 hours the cells were washed and
transferred to a flat-bottom plate. To measure transmission,
activated T-lymphocytes (26105 cells) were added. If indicated the
fusion inhibitory peptide (FIP) Z-d-Phe-L-Phe-Gly-OH (Z-FFG;
0.2 mM; Bachem, Heidelberg, Germany) was added 2 hours later.
For co-culture assays T-lymphocytes (26105 cells), either or not
together with DCs (56104 cells), were pre-incubated with
0,25 mg/ml mannan and infected with different concentrations
of MV-IC323-EGFP.
All cells were cultured for three days at 37uC in complete RPMI-
1640 containing IL-4 and GM-CSF. The cultures were monitored
using a Leica DMIL fluorescence microscope, and pictures were
taken using a Leica DFC 320 camera (Leica Microsystems, Wetzlar,
Germany). At day 3 the cells were harvested, washed and fixed with
4% PFA and EGFP expression was measured by flow cytometry.
DCs had higher autofluorescence compared to T-lymphocytes the
EGFP+ gate for both population was set at the uninfected control
sample. To determine the infection of specific cell populations, the
cells were stained with directly labeled antibodies against DC-SIGN
and CD3 before analysis. The absolute number of infected DCs
(DC-SIGN+/EGFP+) and T cells (CD3+/EGFP+) of the total
counted sample by flow cytometry ( = 105 events) were used to
determine the efficiency of transmission.
Statistical Analysis
To determine the variation in MV transmission among the
different DC donors, the infection of T-lymphocytes was
normalized to the ‘‘medium’’ control condition, which was set at
100%. Subsequently, the percentages of infection from the
different donors were used in a one-way analysis of variance
(ANOVA). When the overall F test was significant, differences
among the donors were further investigated with the post hoc
Bonferroni test using Graphpad Prism software. A probability of
p,0.05 was considered statistically significant.
Supporting Information
Figure S1 DC-SIGN+-dendritic cells are present in the sub-
epithelial tissues of the respiratory tract. Cryosections of different
tissues from healthy donors were stained for the expression of DC-
SIGN (green) and CD150 (red) using specific antibodies, and for
the nuclei using Hoechst (blue). The sections were analyzed by
fluorescence microscopy. Representative photos with a magnifi-
cation of 1006 are depicted (e = epithelium; s = sub-epithelial
tissue, arrow= autofluorescence).
Found at: doi:10.1371/journal.ppat.1000049.s001 (6.29 MB TIF)
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